Head-BannerBG

2ae35fb6-64fc-4e2a-a51e-304ce8b8e187

Monthly newsletter on CitiusTech’s Analyst coverage, insights from recent Analyst interactions, and latest industry reports 

Newsletter-Line-2

Key Analyst Recognitions

Leader in Everest Group Healthcare Payer Digital Services PEAK Matrix Assessment 2023

Read More

1-May-23-2024-02-12-50-1805-AM

Newsletter-Line-2

2-May-23-2024-02-12-51-1286-AM

Horizon 3- Market Leader in HFS Horizons Life Sciences Services Providers, 2023

Read More

Newsletter-Line-2

#1 Major Contender in Everest Healthcare Data & Analytics Services Peak Matrix Assessment 2023

Read More

3-May-23-2024-02-12-51-5026-AM

Newsletter-Line-2

More Awards & Recognitions

Newsletter-Line-2

Analyst Insights

Latest News from the Industry


83% of healthcare provider respondents anticipate they will deploy generative AI (GenAI) within the next three years. Stay competitive and safe by judiciously evaluating GenAI use cases against the anticipated business value and feasibility. Mitigate risk by applying guardrails for experimentation and broader deploymentLine
2024 Top Technology Investments and Objectives for Healthcare Providers; Veronica Walk, Gartner

Read More


83% of healthcare provider respondents anticipate they will deploy generative AI (GenAI) within the next three years. Stay competitive and safe by judiciously evaluating GenAI use cases against the anticipated business value and feasibility. Mitigate risk by applying guardrails for experimentation and broader deploymentLine
2024 Top Technology Investments and Objectives for Healthcare Providers; Veronica Walk, Gartner

Read More


Investment in generative AI (GenAI) is a significant trend, with life science organizations investing heavily in all types of AI in anticipation of potential benefits in areas such as drug discovery, content creation and sales enablement. With these proofs of concept comes some downside risk, and CIOs must select and prioritize projects and partners carefully.Line
2024 Top Technology Investments and Objectives in Life Sciences; Jeff Smith, Gartner

Read More


Investment in generative AI (GenAI) is a significant trend, with life science organizations investing heavily in all types of AI in anticipation of potential benefits in areas such as drug discovery, content creation and sales enablement. With these proofs of concept comes some downside risk, and CIOs must select and prioritize projects and partners carefully.Line
2024 Top Technology Investments and Objectives in Life Sciences; Jeff Smith, Gartner

Read More


CIOs are democratizing digital delivery via AI, low-code/no-code and cloud platforms to excel at CX, improve margins and generate new revenueLine-1
2024 Top Technology Investments and Objectives for U.S. Healthcare Payers; Mandi Bishop, Connie Salgy

Read More


CIOs are democratizing digital delivery via AI, low-code/no-code and cloud platforms to excel at CX, improve margins and generate new revenueLine-1
2024 Top Technology Investments and Objectives for U.S. Healthcare Payers; Mandi Bishop, Connie Salgy

Read More


An enterprise imaging strategy is necessary to effectively govern and manage medical imaging content within and outside the enterprise. Healthcare provider IT and medical imaging leadership should work together to craft an enterprise-wide approach to their medical imaging requirementsLine
Quick Answer: What Is Enterprise Imaging?; Barry Runyon, Gartner

Read More


An enterprise imaging strategy is necessary to effectively govern and manage medical imaging content within and outside the enterprise. Healthcare provider IT and medical imaging leadership should work together to craft an enterprise-wide approach to their medical imaging requirementsLine
Quick Answer: What Is Enterprise Imaging?; Barry Runyon, Gartner

Read More


Home-based healthcare is observing a varying pattern of adoption across the care spectrum. Based on the differential requirements in terms of severity, the adoption of home- based healthcare has been varying across various care types, with primary care having the highest adoption and wellness and lifestyle tracking showing the lowest adoptionLine-1
Rising Adoption of Home- based Healthcare Solutions; Priya Sahni, Kaushik Sundar, Biplab Roy, Everest

Read More


Home-based healthcare is observing a varying pattern of adoption across the care spectrum. Based on the differential requirements in terms of severity, the adoption of home- based healthcare has been varying across various care types, with primary care having the highest adoption and wellness and lifestyle tracking showing the lowest adoptionLine-1
Rising Adoption of Home- based Healthcare Solutions; Priya Sahni, Kaushik Sundar, Biplab Roy, Everest

Read More


Delivering the full potential of technology investments past and future requires investments in AI trust, risk and security management, improvement of exposure management maturity and a fundamentally sustainable approach to technology useLine
Top Strategic Technology Trends for 2024, Bart Willemsen, Gary Olliffe, Arun Chandrasekaran, Gartner

Read More


Delivering the full potential of technology investments past and future requires investments in AI trust, risk and security management, improvement of exposure management maturity and a fundamentally sustainable approach to technology useLine
Top Strategic Technology Trends for 2024, Bart Willemsen, Gary Olliffe, Arun Chandrasekaran, Gartner

Read More

Newsletter-Line-2

Strategic Insights from Analysts for CitiusTech

Pop-Up-Success
Inquiry with Everest

Interoperability Trends

group-1
CitiusTech Attendees

VNSS Mohan, Sridhar T

group-1
Everest Analysts

Kaushik S

Key Takeaway
  • Key market trends in interoperability include cloud adoption for secure data sharing, universal adoption of FHIR HL7, and increased API usage for seamless information flow
  • While the competitive intensity in the care coordination and patient engagement space is high, CitiusTech can differentiate itself by leveraging its capabilities in population health analytics, clinical decision making, and value-based care
  • Leading interoperability platform providers are Intersystems, 1UpHealth, Innovacer, Orion Health
Key Takeaway
  • Key market trends in interoperability include cloud adoption for secure data sharing, universal adoption of FHIR HL7, and increased API usage for seamless information flow
  • While the competitive intensity in the care coordination and patient engagement space is high, CitiusTech can differentiate itself by leveraging its capabilities in population health analytics, clinical decision making, and value-based care
  • Leading interoperability platform providers are Intersystems, 1UpHealth, Innovacer, Orion Health
Pop-Up-Success
In Person Strategy Session

HC Provider Market

group-1
CitiusTech Attendees

John Squeo, Sridhar T, Ravinder Singh,
Siddharth Seth, Srinath Rao

group-1
Everest Analysts

Chunky Satija, Priya Sahni & Kaushik S

Key Takeaway
  • CitiusTech's strategy for achieving the $1 billion revenue milestone should include focusing on home healthcare and mental & behavioral health, establishing partnerships with hyperscalers, expanding their global client footprint, and addressing any feedback regarding domain expertise to meet the higher benchmark set by their specialized offerings
Key Takeaway
  • CitiusTech's strategy for achieving the $1 billion revenue milestone should include focusing on home healthcare and mental & behavioral health, establishing partnerships with hyperscalers, expanding their global client footprint, and addressing any feedback regarding domain expertise to meet the higher benchmark set by their specialized offerings
Pop-Up-Success
Inquiry with Gartner

Medical Imaging

group-1
CitiusTech Attendees

Pushpak Mohley, Kunal Dubey

group-1
Gartner Analysts

Jeff Smith & Barry Runyon

Key Takeaway
  • For many biotech, CROs are the means via which they run trials, and CROs themselves may partner up with medical imaging specialists who can support them
  • Imaging is overwhelmingly needed for Oncology trials, although it may provide supporting evidence for safety for many other trial types. In these cases, when not used directly for trial endpoints, most of this testing is captured as supporting evidence in the EMR and managed by the investigator
  • Many e-clinical vendors have imaging products for more advanced management, such as Medidata, Clario, and Merative. Other eclinical vendors partner for these capabilities
  • More advanced capabilities using AI are impacting imaging technology, as they are for many areas in life science. Tumor recognition, the blue dye process, and other imaging recognition can optimize imaging (such as in the Abbvie GPT example). This will drive interest in imaging platforms that include more advanced techniques
Key Takeaway
  • For many biotech, CROs are the means via which they run trials, and CROs themselves may partner up with medical imaging specialists who can support them
  • Imaging is overwhelmingly needed for Oncology trials, although it may provide supporting evidence for safety for many other trial types. In these cases, when not used directly for trial endpoints, most of this testing is captured as supporting evidence in the EMR and managed by the investigator
  • Many e-clinical vendors have imaging products for more advanced management, such as Medidata, Clario, and Merative. Other eclinical vendors partner for these capabilities
  • More advanced capabilities using AI are impacting imaging technology, as they are for many areas in life science. Tumor recognition, the blue dye process, and other imaging recognition can optimize imaging (such as in the Abbvie GPT example). This will drive interest in imaging platforms that include more advanced techniques
Pop-Up-Success
Strategy Session

Medical Devices

group-1
CitiusTech Attendees

Dhaval Shah, Shujah Dasgupta, Simran Mittal

group-1
Everest Analysts

Chunky Satija & Durga Ambati

Key Takeaway
  • Establishing a secure and interoperable infrastructure is crucial for connected care. To scale Medtech-specific strategic growth offerings, organizations adopt a build-buy-partner approach
  • Connected medical device services have gained significant adoption in pre-care and post-care scenarios across the care continuum
  • MedTech leaders are focusing on building Medtech-specific IP for connectivity, while demand for digital surgery is rising among both MedTech giants and specialized surgical companies
Key Takeaway
  • Establishing a secure and interoperable infrastructure is crucial for connected care. To scale Medtech-specific strategic growth offerings, organizations adopt a build-buy-partner approach
  • Connected medical device services have gained significant adoption in pre-care and post-care scenarios across the care continuum
  • MedTech leaders are focusing on building Medtech-specific IP for connectivity, while demand for digital surgery is rising among both MedTech giants and specialized surgical companies

Newsletter-Line-2

Upcoming Analyst Interactions

Canva Design DAGGBxat2dQ

May 29
Inquiry with Gartner on Interoperability

Canva Design DAGGBxat2dQ

June 03
Briefing with Gartner on Gen AI Quality & Trust framework 

Canva Design DAGGBxat2dQ

June
Healthcare Strategy session with Everest 

Canva Design DAGGBxat2dQ

June
Demo session with Gartner for CitiusTech’s VBC solutions

 

Newsletter-Line-2

IMPORTANT NOTE: Access to Analyst reports is only for internal consumption and usage within CitiusTech. Please DO NOT FORWARD any report to anyone outside the organization.

IMPORTANT NOTE: Access to Analyst reports is only for internal consumption and usage within CitiusTech. Please DO NOT FORWARD any report to anyone outside the organization.